Introduction
The role of Chlamydia trachomatis as a pathogen in the genital tract has been clearly defined,' and it is now considered to be the most common sexually transmitted agent in the Western world.2 However, the establishment of a comprehensive, nationally based service for confirming the diagnosis of a genital chlamydial infection in the United Kingdom remains a major problem. At present the identification of C trachomatis relies on cell culture because the detection of chlamydial antibodies in serum, although of value in establishing the aetiology of infertility,3 4 is not a reliable indication of an uncomplicated current infection in the general population. 5 The laboratory diagnosis of infection with C trachomatis is considered to be time consuming and expensive in terms of initial capital outlay, and has consequently been restricted to a few major centres 
